{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:56:16Z","timestamp":1791356176524,"version":"4.3.1"},"reference-count":50,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":3270,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,10,1]]},"abstract":"<jats:sec>\n                  <jats:title\/>\n                  <jats:p>Lipodystrophies are characterized by a loss of white adipose tissue, which causes ectopic lipid deposition, peripheral insulin resistance, reduced adipokine levels, and increased food intake (hyperphagia). The growth factor myostatin (MSTN) negatively regulates skeletal muscle growth, and mice with MSTN inhibition have reduced adiposity and improved insulin sensitivity. MSTN inhibition may therefore be efficacious in ameliorating diabetes. To test this hypothesis, we inhibited MSTN signaling in a diabetic model of generalized lipodystrophy to analyze its effects on glucose metabolism separate from effects on adipose mass. A-ZIP\/F1 lipodystrophic mice were crossed to mice expressing a dominant-negative MSTN receptor (activin receptor type IIB) in muscle. MSTN inhibition in A-ZIP\/F1 mice reduced blood glucose, serum insulin, triglyceride levels, and the rate of triglyceride synthesis, and improved insulin sensitivity. Unexpectedly, hyperphagia was normalized by MSTN inhibition in muscle. Blood glucose and hyperphagia were reduced in double mutants independent of the adipokine leptin. These results show that the effect of MSTN inhibition on insulin sensitivity is not secondary to an effect on adipose mass and that MSTN inhibition may be an effective treatment for diabetes. These results further suggest that muscle may play a heretofore unappreciated role in regulating food intake.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db11-0915","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T05:36:06Z","timestamp":1337319366000},"page":"2414-2423","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":59,"title":["Myostatin Inhibition Prevents Diabetes and Hyperphagia in a Mouse Model of Lipodystrophy"],"prefix":"10.2337","volume":"61","author":[{"given":"Tingqing","family":"Guo","sequence":"first","affiliation":[{"name":"Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichole D.","family":"Bond","sequence":"additional","affiliation":[{"name":"Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jou","sequence":"additional","affiliation":[{"name":"Mouse Metabolic Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Gavrilova","sequence":"additional","affiliation":[{"name":"Mouse Metabolic Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Portas","sequence":"additional","affiliation":[{"name":"Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra C.","family":"McPherron","sequence":"additional","affiliation":[{"name":"Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2012,9,13]]},"reference":[{"key":"2022031208593856100_B1","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"2022031208593856100_B2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","article-title":"Lipodystrophy: pathophysiology and advances in treatment","volume":"7","author":"Fiorenza","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2022031208593856100_B3","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","article-title":"Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients","volume":"87","author":"Chen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031208593856100_B4","first-page":"507","article-title":"Disordered lipid metabolism and the pathogenesis of insulin resistance","volume":"87","author":"Savage","year":"2007","journal-title":"Physiol ev"},{"key":"2022031208593856100_B5","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipid-induced insulin resistance: unravelling the mechanism","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"key":"2022031208593856100_B6","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031208593856100_B7","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1074\/jbc.275.12.8456","article-title":"Mechanism of insulin resistance in A-ZIP\/F-1 fatless mice","volume":"275","author":"Kim","year":"2000","journal-title":"J Biol Chem"},{"key":"2022031208593856100_B8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1242\/dmm.002907","article-title":"Mouse models of inherited lipodystrophy","volume":"2","author":"Savage","year":"2009","journal-title":"Dis Model Mech"},{"key":"2022031208593856100_B9","doi-asserted-by":"crossref","first-page":"980S","DOI":"10.3945\/ajcn.2008.26788C","article-title":"Leptin: a pivotal regulator of human energy homeostasis","volume":"89","author":"Farooqi","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"2022031208593856100_B10","first-page":"125","article-title":"The clinical utility of leptin therapy in metabolic dysfunction","volume":"31","author":"Park","year":"2006","journal-title":"Minerva Endocrinol"},{"key":"2022031208593856100_B11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOL.0b013e32832d4a33","article-title":"Inherited lipodystrophies and hypertriglyceridemia","volume":"20","author":"Simha","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"2022031208593856100_B12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1530\/EJE-09-1027","article-title":"Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin","volume":"162","author":"Beltrand","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2022031208593856100_B13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/187152210793663748","article-title":"Extracellular regulation of myostatin: a molecular rheostat for muscle mass.","volume":"10","author":"Lee","year":"2010","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"key":"2022031208593856100_B14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/187152210793663810","article-title":"Metabolic functions of myostatin and GDF11","volume":"10","author":"McPherron","year":"2010","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"key":"2022031208593856100_B15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/187152210793663766","article-title":"Developmental role for myostatin in regulating myogenesis","volume":"10","author":"Otto","year":"2010","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"key":"2022031208593856100_B16","doi-asserted-by":"crossref","first-page":"e4937","DOI":"10.1371\/journal.pone.0004937","article-title":"Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity","volume":"4","author":"Guo","year":"2009","journal-title":"PLoS One"},{"key":"2022031208593856100_B17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.ijo.0803200","article-title":"Resistance to body fat gain in \u2018double-muscled\u2019 mice fed a high-fat diet","volume":"30","author":"Hamrick","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"2022031208593856100_B18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2337\/db08-0245","article-title":"Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance","volume":"58","author":"Wilkes","year":"2009","journal-title":"Diabetes"},{"key":"2022031208593856100_B19","doi-asserted-by":"crossref","first-page":"E918","DOI":"10.1152\/ajpendo.00798.2007","article-title":"Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice","volume":"294","author":"Allen","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031208593856100_B20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/db08-0943","article-title":"Increased secretion and expression of myostatin in skeletal muscle from extremely obese women","volume":"58","author":"Hittel","year":"2009","journal-title":"Diabetes"},{"key":"2022031208593856100_B21","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/jc.2003-032047","article-title":"Changes in muscle myostatin expression in obese subjects after weight loss","volume":"89","author":"Milan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031208593856100_B22","doi-asserted-by":"crossref","first-page":"e6575","DOI":"10.1371\/journal.pone.0006575","article-title":"Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways","volume":"4","author":"Palsgaard","year":"2009","journal-title":"PLoS One"},{"key":"2022031208593856100_B23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1152\/physiolgenomics.00045.2006","article-title":"GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle","volume":"27","author":"Park","year":"2006","journal-title":"Physiol Genomics"},{"key":"2022031208593856100_B24","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1249\/MSS.0b013e3181e0b9a8","article-title":"Myostatin decreases with aerobic exercise and associates with insulin resistance","volume":"42","author":"Hittel","year":"2010","journal-title":"Med Sci Sports Exerc"},{"key":"2022031208593856100_B25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/HCR.0b013e318199ff69","article-title":"Resistance training in the treatment of diabetes and obesity: mechanisms and outcomes","volume":"29","author":"Tresierras","year":"2009","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"2022031208593856100_B26","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031208593856100_B27","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1101\/gad.12.20.3168","article-title":"Life without white fat: a transgenic mouse","volume":"12","author":"Moitra","year":"1998","journal-title":"Genes Dev"},{"key":"2022031208593856100_B28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbrc.2005.09.044","article-title":"Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance","volume":"337","author":"Zhao","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2022031208593856100_B29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1172\/JCI8437","article-title":"Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism","volume":"105","author":"Yu","year":"2000","journal-title":"J Clin Invest"},{"key":"2022031208593856100_B30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmet.2006.09.008","article-title":"Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency","volume":"4","author":"Gautam","year":"2006","journal-title":"Cell Metab"},{"key":"2022031208593856100_B31","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1074\/jbc.M207665200","article-title":"Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice. Role of triglyceride clearance","volume":"278","author":"Colombo","year":"2003","journal-title":"J Biol Chem"},{"key":"2022031208593856100_B32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ddmod.2007.10.003","article-title":"Mouse models of lipodystrophy key reagents for the understanding of the metabolic syndrome","volume":"4","author":"Asterholm","year":"2007","journal-title":"Drug Discov Today Dis Models"},{"key":"2022031208593856100_B33","doi-asserted-by":"crossref","first-page":"e11307","DOI":"10.1371\/journal.pone.0011307","article-title":"Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice","volume":"5","author":"Bernardo","year":"2010","journal-title":"PLoS One"},{"key":"2022031208593856100_B34","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.emboj.7600082","article-title":"Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice","volume":"23","author":"Cooney","year":"2004","journal-title":"EMBO J"},{"key":"2022031208593856100_B35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.physbeh.2009.03.027","article-title":"Control of energy homeostasis by insulin and leptin: targeting the arcuate nucleus and beyond","volume":"97","author":"K\u00f6nner","year":"2009","journal-title":"Physiol Behav"},{"key":"2022031208593856100_B36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/385165a0","article-title":"Role of melanocortinergic neurons in feeding and the agouti obesity syndrome","volume":"385","author":"Fan","year":"1997","journal-title":"Nature"},{"key":"2022031208593856100_B37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.physbeh.2010.03.019","article-title":"Glucagon regulation of energy metabolism","volume":"100","author":"Heppner","year":"2010","journal-title":"Physiol Behav"},{"key":"2022031208593856100_B38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2009.06.005","article-title":"Gut hormones: implications for the treatment of obesity","volume":"124","author":"Neary","year":"2009","journal-title":"Pharmacol Ther"},{"key":"2022031208593856100_B39","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.ijo.0802142","article-title":"Leptin: a review of its peripheral actions and interactions","volume":"26","author":"Margetic","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2022031208593856100_B40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmet.2007.11.003","article-title":"Fast\/glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice","volume":"7","author":"Izumiya","year":"2008","journal-title":"Cell Metab"},{"key":"2022031208593856100_B41","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2337\/diabetes.50.6.1440","article-title":"Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes","volume":"50","author":"Ebihara","year":"2001","journal-title":"Diabetes"},{"key":"2022031208593856100_B42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"2022031208593856100_B43","doi-asserted-by":"crossref","first-page":"19285","DOI":"10.1073\/pnas.0709778104","article-title":"Regulation of hypothalamic malonyl-CoA by central glucose and leptin","volume":"104","author":"Wolfgang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031208593856100_B44","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.2337\/diacare.28.12.2884","article-title":"Modulation of food intake by glucose in patients with type 2 diabetes","volume":"28","author":"Schultes","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031208593856100_B45","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1365-2826.2008.1730.x","article-title":"Adipose tissue hormones and the regulation of food intake","volume":"20","author":"Henry","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"2022031208593856100_B46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1507\/endocrj.K10E-077","article-title":"The role of gut hormones and the hypothalamus in appetite regulation","volume":"57","author":"Suzuki","year":"2010","journal-title":"Endocr J"},{"key":"2022031208593856100_B47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm0410-392","article-title":"Neuronal regulation of homeostasis by nutrient sensing","volume":"16","author":"Lam","year":"2010","journal-title":"Nat Med"},{"key":"2022031208593856100_B48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000264397","article-title":"Hypothalamic nutrient sensing and energy balance","volume":"63","author":"Moran","year":"2010","journal-title":"Forum Nutr"},{"key":"2022031208593856100_B49","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1172\/JCI36714","article-title":"Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents","volume":"119","author":"Benoit","year":"2009","journal-title":"J Clin Invest"},{"key":"2022031208593856100_B50","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.2337\/db07-1788","article-title":"Role of central nervous system glucagon-like peptide-1 receptors in enteric glucose sensing","volume":"57","author":"Knauf","year":"2008","journal-title":"Diabetes"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/61\/10\/2414\/559682\/2414.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/61\/10\/2414\/559682\/2414.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:27:43Z","timestamp":1667406463000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/61\/10\/2414\/14669\/Myostatin-Inhibition-Prevents-Diabetes-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,13]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2012,9,13]]},"published-print":{"date-parts":[[2012,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db11-0915","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,13]]}}}